Effect of Angiotensin Receptor Blockers on Renal Function Biomarkers in  Early-Stage Diabetic Nephropathy

Early-Stage Diabetic Nephropathy Shabana Aziz, Sibgha Usman, Farooq Sultan, Irfan Ahmad, Syed Azhar Hussain Zaidi, Muhammad Usman

Effect of Angiotensin Receptor Blockers on Renal Function Biomarkers in Early-Stage Diabetic Nephropathy

Authors

Early-Stage Diabetic Nephropathy Shabana Aziz, Sibgha Usman, Farooq Sultan, Irfan Ahmad, Syed Azhar Hussain Zaidi, Muhammad Usman

Keywords:

angiotensin receptor blockers; diabetic nephropathy; renal biomarkers.

Abstract

Angiotensin receptor blockers (ARBs) are established agents in slowing diabetic nephropathyprogression; however, their impact on emerging biomarkers in early-stage disease remains underexplored. In this randomized experimental trial, 140 type 2 diabetic patients

References

Tuttle KR, et al. Early biomarker changes with ARB therapy in diabetic nephropathy. Kidney Int Rep. 2022;7(3):397–406.

Zhao H, et al. Urinary NGAL as predictor of tubular injury in diabetes. Clin J Am Soc Nephrol. 2021;16(10):1495–1503.

Downloads

Published

2025-07-28

How to Cite

Early-Stage Diabetic Nephropathy Shabana Aziz, Sibgha Usman, Farooq Sultan, Irfan Ahmad, Syed Azhar Hussain Zaidi, Muhammad Usman. (2025). Effect of Angiotensin Receptor Blockers on Renal Function Biomarkers in Early-Stage Diabetic Nephropathy . International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 775–781. Retrieved from https://ijprt.org/index.php/pub/article/view/779